↓ Skip to main content

T cell engineering for adoptive T cell therapy: safety and receptor avidity

Overview of attention for article published in Cancer Immunology, Immunotherapy, September 2019
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (62nd percentile)
  • Good Attention Score compared to outputs of the same age and source (65th percentile)

Mentioned by

twitter
8 X users

Citations

dimensions_citation
40 Dimensions

Readers on

mendeley
93 Mendeley
Title
T cell engineering for adoptive T cell therapy: safety and receptor avidity
Published in
Cancer Immunology, Immunotherapy, September 2019
DOI 10.1007/s00262-019-02395-9
Pubmed ID
Authors

Elvira D’Ippolito, Kilian Schober, Magdalena Nauerth, Dirk H. Busch

X Demographics

X Demographics

The data shown below were collected from the profiles of 8 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 93 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 93 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 20 22%
Researcher 16 17%
Student > Master 9 10%
Student > Doctoral Student 7 8%
Student > Bachelor 7 8%
Other 6 6%
Unknown 28 30%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 19 20%
Immunology and Microbiology 14 15%
Agricultural and Biological Sciences 11 12%
Medicine and Dentistry 7 8%
Engineering 4 4%
Other 5 5%
Unknown 33 35%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 November 2019.
All research outputs
#7,229,289
of 23,577,654 outputs
Outputs from Cancer Immunology, Immunotherapy
#979
of 2,948 outputs
Outputs of similar age
#126,830
of 344,781 outputs
Outputs of similar age from Cancer Immunology, Immunotherapy
#16
of 46 outputs
Altmetric has tracked 23,577,654 research outputs across all sources so far. This one has received more attention than most of these and is in the 68th percentile.
So far Altmetric has tracked 2,948 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.2. This one has gotten more attention than average, scoring higher than 64% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 344,781 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 62% of its contemporaries.
We're also able to compare this research output to 46 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 65% of its contemporaries.